Literature DB >> 25370856

Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.

Eero Rissanen1, Jouni Tuisku2, Pauliina Luoto2, Eveliina Arponen2, Jarkko Johansson2, Vesa Oikonen2, Riitta Parkkola3, Laura Airas4, Juha O Rinne1.   

Abstract

[(11)C]TMSX ([7-N-methyl-(11)C]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine) is a selective adenosine A2A receptor (A2AR) radioligand. In the central nervous system (CNS), A2AR are linked to dopamine D2 receptor function in striatum, but they are also important modulators of inflammation. The golden standard for kinetic modeling of brain [(11)C]TMSX positron emission tomography (PET) is to obtain arterial input function via arterial blood sampling. However, this method is laborious, prone to errors and unpleasant for study subjects. The aim of this work was to evaluate alternative input function acquisition methods for brain [(11)C]TMSX PET imaging. First, a noninvasive, automated method for the extraction of gray matter reference region using supervised clustering (SCgm) was developed. Second, a method for obtaining a population-based arterial input function (PBIF) was implemented. These methods were created using data from 28 study subjects (7 healthy controls, 12 multiple sclerosis patients, and 9 patients with Parkinson's disease). The results with PBIF correlated well with original plasma input, and the SCgm yielded similar results compared with cerebellum as a reference region. The clustering method for extracting reference region and the population-based approach for acquiring input for dynamic [(11)C]TMSX brain PET image analyses appear to be feasible and robust methods, that can be applied in patients with CNS pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370856      PMCID: PMC4294409          DOI: 10.1038/jcbfm.2014.194

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.

Authors:  K Ishiwata; J Noguchi; S Wakabayashi; J Shimada; N Ogi; T Nariai; A Tanaka; K Endo; F Suzuki; M Senda
Journal:  J Nucl Med       Date:  2000-02       Impact factor: 10.057

2.  Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists.

Authors:  Akihisa Mori; Tomomi Shindou
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

3.  Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-α2 controlling glutamate uptake in astrocytes.

Authors:  Marco Matos; Elisabete Augusto; Paula Agostinho; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

4.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

5.  Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.

Authors:  P Popoli; C Frank; M T Tebano; R L Potenza; A Pintor; M R Domenici; V Nazzicone; A Pèzzola; R Reggio
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

Review 6.  Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities.

Authors:  Bertil B Fredholm; Per Svenningsson
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

7.  Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.

Authors:  Robert A Hauser; C Warren Olanow; Karl D Kieburtz; Emmanuelle Pourcher; Any Docu-Axelerad; Mark Lew; Olexandr Kozyolkin; Ann Neale; Chris Resburg; Uwe Meya; Christopher Kenney; Stephen Bandak
Journal:  Lancet Neurol       Date:  2014-07-06       Impact factor: 44.182

8.  Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

Authors:  Eero Rissanen; Jere R Virta; Teemu Paavilainen; Jouni Tuisku; Semi Helin; Pauliina Luoto; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-22       Impact factor: 6.200

9.  Reference region automatic extraction in dynamic [(11)C]PIB.

Authors:  Yoko Ikoma; Paul Edison; Anil Ramlackhansingh; David J Brooks; Federico E Turkheimer
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

10.  Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.

Authors:  Yoshikuni Mizuno; Tomoyoshi Kondo
Journal:  Mov Disord       Date:  2013-03-11       Impact factor: 10.338

View more
  18 in total

1.  Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.

Authors:  Daniel García-Lorenzo; Sonia Lavisse; Claire Leroy; Catriona Wimberley; Benedetta Bodini; Philippe Remy; Mattia Veronese; Federico Turkheimer; Bruno Stankoff; Michel Bottlaender
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-09       Impact factor: 6.200

2.  Development of a clinically feasible [11C]PE2I PET method for differential diagnosis of parkinsonism using reduced scan duration and automated reference region extraction.

Authors:  My Jonasson; Lieuwe Appel; Torsten Danfors; Dag Nyholm; Håkan Askmark; Andreas Frick; Jonas Engman; Tomas Furmark; Jens Sörensen; Mark Lubberink
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-12-20

3.  Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value.

Authors:  Maria Elisa Serrano; Mohamed Ali Bahri; Guillaume Becker; Alain Seret; Frédéric Mievis; Fabrice Giacomelli; Christian Lemaire; Eric Salmon; André Luxen; Alain Plenevaux
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

4.  Effect of Region of Interest Size on the Repeatability of Quantitative Brain Imaging Biomarkers.

Authors:  Kourosh Jafari-Khouzani; Kamran Paynabar; Fatemeh Hajighasemi; Bruce Rosen
Journal:  IEEE Trans Biomed Eng       Date:  2018-07-27       Impact factor: 4.538

Review 5.  Positron emission tomography in multiple sclerosis - straight to the target.

Authors:  Benedetta Bodini; Matteo Tonietto; Laura Airas; Bruno Stankoff
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

6.  Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson's disease.

Authors:  Imran Waggan; Eero Rissanen; Jouni Tuisku; Juho Joutsa; Semi Helin; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Neurol       Date:  2022-09-02       Impact factor: 6.682

7.  Total-Body Quantitative Parametric Imaging of Early Kinetics of 18F-FDG.

Authors:  Tao Feng; Yizhang Zhao; Hongcheng Shi; Hongdi Li; Xuezhu Zhang; Guobao Wang; Patricia M Price; Ramsey D Badawi; Simon R Cherry; Terry Jones
Journal:  J Nucl Med       Date:  2020-09-18       Impact factor: 10.057

8.  Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.

Authors:  Rostom Mabrouk; Antonio P Strafella; Dunja Knezevic; Christine Ghadery; Romina Mizrahi; Avideh Gharehgazlou; Yuko Koshimori; Sylvain Houle; Pablo Rusjan
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

Review 9.  Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.

Authors:  Pekka Poutiainen; Merja Jaronen; Francisco J Quintana; Anna-Liisa Brownell
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

Review 10.  In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.

Authors:  Anna Vuorimaa; Eero Rissanen; Laura Airas
Journal:  Contrast Media Mol Imaging       Date:  2017-11-20       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.